TAUBERT JENNIFER L (EVP, WW Chair, Pharmaceuticals) sold 7.2% of their position (15K shares) of JOHNSON & JOHNSON on the open market
Open‑market sale worth $3.95M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2026ACC: 0000200406-26-000175
Officer· EVP, WW Chair, Pharmaceuticals
Since Jul 2018
-15K
Net shares
Net seller
$3.95M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$115.67
Trade value
$1.74M
% of position
7.7%
8/17/2026
194.45K→209.45K
Common Stock
Direct
Shares
−15K
Price / share
$263.36
Trade value
$3.95M
% of position
7.2%
8/17/2026
209.45K→194.45K
Total
Net shares
+0.00
Net value
-$2.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | M · Option Exercise | +15K | $115.67 | $1.74M | 7.7% | 194.45K | 209.45K |
| Common Stock Direct | 8/17/2026 | S · Sale | −15K | $263.36 | $3.95M | 7.2% | 209.45K | 194.45K |
| Total | +0.00 | -$2.22M | ||||||
Derivative Transactions1
Employee Stock Options (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
115.67
Held after
28.71K
Exercisable
—
8/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy) Direct | Common Stock15K shares | 8/17/2026 | M · Option Exercise | −15K | 115.67 | — | 28.71K |